Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J, Joly F, Marreaud S, Collette L, Sylvester R; European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group; Groupe d'Etude des Tumeurs Urogénitales; National Cancer Research Institute Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; German Association of Urologic Oncology. Sternberg CN, et al. Among authors: charpentier d. Lancet Oncol. 2015 Jan;16(1):76-86. doi: 10.1016/S1470-2045(14)71160-X. Epub 2014 Dec 11. Lancet Oncol. 2015. PMID: 25498218 Free article. Clinical Trial.
Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115.
Maroun JA, Belanger K, Seymour L, Matthews S, Roach J, Dionne J, Soulieres D, Stewart D, Goel R, Charpentier D, Goss G, Tomiak E, Yau J, Jimeno J, Chiritescu G; National Cancer Institute of Canada Clinical Trials Group. Maroun JA, et al. Among authors: charpentier d. Ann Oncol. 2006 Sep;17(9):1371-8. doi: 10.1093/annonc/mdl165. Ann Oncol. 2006. PMID: 16966366 Free article. Clinical Trial.
Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
Hirsh V, Soulieres D, Duclos M, Faria S, Del Vecchio P, Ofiara L, Ayoub JP, Charpentier D, Gruber J, Portelance L, Souhami L. Hirsh V, et al. Among authors: charpentier d. J Thorac Oncol. 2007 Oct;2(10):927-32. doi: 10.1097/JTO.0b013e3181560b92. J Thorac Oncol. 2007. PMID: 17909355 Free article. Clinical Trial.
Concurrent chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: is more always better?
Barkati M, Fortin B, Soulières D, Clavel S, Després P, Charpentier D, Tabet JC, Guertin L, Olivier MJ, Coulombe G, Donath D, Nguyen-Tan PF. Barkati M, et al. Among authors: charpentier d. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):410-6. doi: 10.1016/j.ijrobp.2009.02.034. Epub 2009 May 8. Int J Radiat Oncol Biol Phys. 2010. PMID: 19427745
Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.
Clavel S, Fortin B, Després P, Donath D, Soulières D, Khaouam N, Charpentier D, Bélair M, Guertin L, Nguyen-Tan PF. Clavel S, et al. Among authors: charpentier d. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):763-9. doi: 10.1016/j.ijrobp.2009.12.032. Epub 2010 May 24. Int J Radiat Oncol Biol Phys. 2011. PMID: 20510546
65 results